Get the App

Back Stocks profile

Stock analysis tool for investors

Dr. Reddy's Laboratories Ltd.

₹5794.30 17.85 (0.31%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

5785.00

Today’s High

5820.00

52W low

4175.10

52W High

5989.70

Open Price

5796.00

Prev. Close

5478.55

Volume

18082.00

Value

104772532.60

Fundamentals

Market Cap Cr

96649.00

Price to Earnings

19.00

Price to Book Value

4.20

Dividend Yield

0.70

PE to Growth

0.30

Op Revenue TTM Cr

26765.50

Net Profit TTM Cr

5091.20

Cash From Operating Activity Cr

5887.50

Return on Equity %

19.35

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA Rs

5747.6

10Day EMA Rs

5701

12Day EMA Rs

5683.3

20Day EMA Rs

5629.7

26Day EMA Rs

5605.5

50Day EMA Rs

5560

100Day EMA Rs

5453.1

200Day EMA Rs

5209.6

5Day SMA Rs

5757.1

10Day SMA Rs

5706.3

20Day SMA Rs

5592.7

30Day SMA Rs

5524.6

50Day SMA Rs

5516.6

100Day SMA Rs

5568.9

150Day SMA Rs

5307.3

200Day SMA Rs

5125.2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Dec, 2023

51.9

Week

56.5

Month

53.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5779.15

PIVOT

First Resistance

5816.30

Second Resistance

5856.15

Third Resistance

5893.30

First Support

5739.30

Second Support

5702.15

Third Support

5662.30

Relative Strength Index

67.95

Money Flow Index

84.67

MACD

77.74

MACD Signal

54.91

Average True Range

93.41

Average Directional Index

21.98

Rate of Change (21)

9.75

Rate of Change (125)

25.48

Commodity Channel Index

102.5

Williams %R

-17.7

BETA

1 Month

0.12

3 Month

0.3

1 Year

0.12

3 Year

0.04

PRICE CHANGE ANALYSIS

↑ 2.09%

1 Week

Low

High

5654

5856.55

↑ 10.09%

1 Month

Low

High

5283.2

5856.55

↑ 3.86%

3 Months

Low

High

5205.55

5856.55

↑ 25.87%

6 Months

Low

High

4605

5989.7

↑ 29.35%

1 Year

Low

High

4175.1

5989.7

Indicator Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Graph
Total Qtr Revenue cr 5061.80 5670.90 4668.80 3949.00 4998.30 4034.00 3783.40 3542.60 3941.50 3619.70 3432.30
Operating Expenses Qtr Cr 3209.60 3209.60 3488.80 3221.50 3077.50 3051.10 2989.00 2865.60 3075.10 2871.60 2747.80
Operating Profit Qtr Cr 1629.10 2227.70 1061.10 675.10 1802.80 579.50 669.90 614.00 748.30 561.90 602.90
EBIDT Qtr Cr 1852.20 2461.30 1175.90 726.50 1920.80 982.90 784.60 677.00 866.40 748.10 684.50
Depreciation Qtr Cr 245.80 237.20 236.70 238.80 226.20 221.50 205.20 205.40 206.60 197.10 210.70
Net Profit Qtr Cr 1192.60 1639.40 672.40 324.60 1116.30 499.50 419.70 341.10 449.00 413.40 311.50
Basic EPS Qtr Rs 71.68 98.66 40.49 19.54 67.25 30.10 25.29 20.55 27.07 24.94 18.78
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual Cr 17553.80 14887.20 14150.20 12593.60 10863.90
Operating Expenses Annual Cr 12747.70 11811.10 10212.30 8980.80 8325.80
Operating Profit Annual in Cr 4214.80 2594.10 3136.80 2869.60 2299.70
Operating Profit Margin Annual % 24.01 17.43 22.17 22.79 21.17
Total Expenses Annual Cr 13687.80 12663.40 11094.00 9817.80 9163.20
EBIDT Annual Cr 4806.10 3076.10 3937.90 3612.80 2538.10
EBIDT Annual margin % 27.38 20.66 27.83 28.69 23.36
Depreciation Cr 923.20 814.30 835.00 789.20 780.60
PAT Before ExtraOrdinary Items Annual Cr 2612.80 1623.20 2186.40 2937.70 1277.30
Net Profit Annual Cr 2612.80 1623.20 2186.40 2937.70 1277.30
Basic EPS Annual Rs 157.37 97.85 131.84 177.23 76.98
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual Cr 20474.20 18336.20 16983.70 15191.90 12684.10
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 460.90 114.30 85.60 103.40 484.10
Total Current Liabilities Annual Cr 4439.70 6045.10 4560.30 4180.50 3079.30
Total Capital Plus Liabilities Annual Cr 25374.80 24495.60 21629.60 19475.80 16247.50
Fixed Assets Annual Cr 8119.70 7350.80 6745.10 4845.70 5082.80
Total Non Current Assets Annual Cr 11586.50 11012.00 10685.40 9369.10 7314.30
Total Current Assets Annual Cr 13788.30 13483.60 10944.20 10106.70 8933.20
Total Assets Annual Cr 25374.80 24495.60 21629.60 19475.80 16247.50
Contingent Liabilities plus Commitments Annual Cr 830.20 827.40 1062.80 1068.60 696.50
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual Cr 5052.90 1338.70 3514.20 1839.20 2762.10
Cash from Investing Activity Annual Cr -3447.60 -2038.00 -1458.00 -1689.20 -550.90
Cash from Financing Annual Activity Cr -2696.90 505.50 -794.30 -224.10 -2223.10
Net Cash Flow Annual Cr -1091.60 -193.80 1261.90 -74.10 -11.90
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual Rs 1228.94 1101.93 1020.65 914.07 764.10
ROE Annual % 12.76 8.85 12.87 19.33 10.07
ROCE Annual % 18.54 12.25 18.17 18.46 13.34
Total Debt to Total Equity Annual 0.00 0.12 0.07 0.07 0.07
EBDIT Annual Margin % 28.33 21.35 29.49 30.48 23.88
Indicator Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Graph
Total Qtr Revenue cr 7217.60 6931.90 6453.70 6848.50 6372.60 6086.80 5596.80 5394.10 5992.40 5053.00 4850.80
Operating Expenses Qtr Cr 4888.80 4694.70 4727.30 4837.90 4430.40 4291.70 4282.00 4117.90 4427.10 4210.60 3713.50
Operating Profit Qtr Cr 2008.30 2062.10 1533.90 1938.50 1898.90 941.20 451.00 1215.70 1359.80 734.50 1053.20
EBIDT Qtr Cr 2323.30 2236.10 1672.40 1997.20 1939.70 1795.10 572.90 1271.50 1565.30 842.40 1135.80
Depreciation Qtr Cr 375.50 353.30 315.50 323.70 309.20 301.80 293.00 294.20 294.10 283.90 308.80
Net Profit Qtr Cr 1482.20 1405.00 960.10 1243.90 1114.20 1189.00 97.00 709.30 995.80 380.40 557.30
Basic EPS Qtr Rs 89.09 84.55 57.79 74.91 67.13 71.64 5.84 42.75 60.03 22.95 33.61
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual Cr 25725.20 22029.60 19338.90 18137.60 15785.70
Operating Expenses Annual Cr 18320.70 17777.50 15177.60 15046.60 12270.00
Operating Profit Annual in Cr 6349.00 3767.70 3869.90 2470.40 3178.20
Operating Profit Margin Annual % 24.68 17.10 20.01 13.62 20.13
Total Expenses Annual Cr 19713.70 19038.50 16503.40 16308.00 13493.70
EBIDT Annual Cr 7404.50 4252.10 4161.30 3091.00 3515.70
EBIDT Annual margin % 28.78 19.30 21.52 17.04 22.27
Depreciation Cr 1250.20 1165.20 1228.80 1163.10 1134.80
PAT Before ExtraOrdinary Items Annual Cr 4470.30 2112.20 1903.60 1969.90 1906.20
Net Profit Annual Cr 4507.30 2182.50 1951.60 2026.00 1950.00
Basic EPS Annual Rs 270.90 131.21 117.34 121.99 117.33
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual Cr 23286.10 19212.40 17641.70 15598.80 14023.60
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 426.90 768.70 871.30 412.40 2544.70
Total Current Liabilities Annual Cr 8572.10 9765.80 8103.80 7214.10 5897.30
Total Capital Plus Liabilities Annual Cr 32285.10 29746.90 26616.80 23225.30 22465.60
Fixed Assets Annual Cr 9701.80 8867.60 9210.90 7894.10 9658.60
Total Non Current Assets Annual Cr 11859.60 11964.60 12066.50 10626.20 11355.50
Total Current Assets Annual Cr 20425.50 17782.30 14550.30 12599.10 11110.10
Total Assets Annual Cr 32285.10 29746.90 26616.80 23225.30 22465.60
Contingent Liabilities plus Commitments Annual Cr 929.80 936.80 1077.40 1040.60 577.90
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual Cr 5887.50 2810.80 3570.30 2984.10 2870.40
Cash from Investing Activity Annual Cr -4137.30 -2638.70 -2266.00 -492.30 -772.70
Cash from Financing Annual Activity Cr -2686.10 -242.20 -29.80 -2515.90 -2132.60
Net Cash Flow Annual Cr -935.90 -70.10 1274.50 -24.10 -34.90
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual Rs 1397.72 1154.59 1060.20 938.56 844.79
ROE Annual % 19.35 11.35 11.06 12.98 13.90
ROCE Annual % 25.95 15.44 15.84 12.04 14.37
Total Debt to Total Equity Annual 0.05 0.16 0.15 0.11 0.24
EBDIT Annual Margin % 30.01 19.73 21.84 17.64 22.75
Name Holding Percent Holding Id Pledged % Locked %
HDFC TRUSTEE COMPANY LTD. A/C HDFC NIFTY 50 ETF 1.75 10731590 - -
HDFC LIFE INSURANCE COMPANY LIMITED 1.04 10731594 - -
NPS TRUST-A/C SBI PENSION FUND SCHEME TAX SAVER-TIER 2 2.09 10731596 - -
GOVERNMENT OF SINGAPORE 1.21 10731603 - -
Name Holding Percent Holding Id Pledged % Locked %
KALLAM SATISH REDDY HUF 3.31 10731573 0 0
GUNUPATI VENKATESWARA PRASAD HUF 1.52 10731574 0 0
SAMRAJYAM REDDY KALLAM 0.67 10731575 0 0
SATISH REDDY KALLAM 0.54 10731576 0 0
APS Trust 20.59 10731586 0 0
Name Holding Percent Holding Id
HDFC TRUSTEE COMPANY LTD. A/C HDFC NIFTY 50 ETF 1.75 10731590
SBI-ETF NIFTY 50 1.67 10731591
FIRST SENTIER INVESTORS ICVC - STEWART INVESTORS ASIA PACIFIC LEADERS SUSTAINABILITY FUND 2.32 10731602
GOVERNMENT OF SINGAPORE 1.21 10731603
LIFE INSURANCE CORPORATION OF INDIA P & GS FUND 7.34 10731593
HDFC LIFE INSURANCE COMPANY LIMITED 1.04 10731594
J P Morgan Chase Bank NA 14.02 10731599
NPS TRUST-A/C SBI PENSION FUND SCHEME TAX SAVER-TIER 2 2.09 10731596
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Jul 11, 2023 40 FINAL - Equity Share
Jul 11, 2022 30 FINAL - Equity Share
Jul 09, 2021 25 FINAL - Equity Share
Jul 13, 2020 25 FINAL - Equity Share
Jul 15, 2019 20 FINAL - Equity Share
Jul 16, 2018 20 FINAL - Equity Share
Jul 17, 2017 20 FINAL - Equity Share
Jul 18, 2016 20 FINAL - Equity Share
Jul 10, 2015 20 FINAL - Equity Share
Jul 11, 2014 18 FINAL - Equity Share
Jul 12, 2013 15 FINAL - Equity Share
Jun 28, 2012 13.75 FINAL - Equity Share
Jun 30, 2011 11.25 FINAL - Equity Share
Jul 02, 2010 11.25 FINAL - Equity Share
Jul 03, 2009 6.25 FINAL - Equity Share
Jul 04, 2008 3.75 FINAL - Equity Share
Jul 06, 2007 3.75 FINAL - Equity Share
Jul 07, 2006 5 FINAL - Equity Share
Jul 07, 2005 5 FINAL - Equity Share
Jul 13, 2004 5 FINAL - Equity Share
Aug 08, 2003 5 FINAL - Equity Share
Aug 08, 2002 - FINAL - Equity Share
Nov 08, 2001 - INTERIM Nov 26, 2001 Equity Share
Jun 18, 2001 - FINAL - Equity Share
Sep 07, 2000 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Oct 10, 2001 10:5 2001-10-25
Ex-Date Purpose Notes
Oct 27, 2023 Quarterly Results -
Jul 26, 2023 Quarterly Results -
May 10, 2023 Audited Results & Final Dividend -
Jan 25, 2023 Quarterly Results -
Oct 28, 2022 Quarterly Results -
Jul 28, 2022 Quarterly Results -
May 19, 2022 Audited Results & Final Dividend -
Jan 28, 2022 Quarterly Results -
Oct 29, 2021 Quarterly Results -
Jul 27, 2021 Quarterly Results -
May 14, 2021 Audited Results & Final Dividend -
Jan 29, 2021 Quarterly Results -
Oct 28, 2020 Quarterly Results -
Jul 29, 2020 Quarterly Results -
May 20, 2020 Audited Results & Final Dividend (Revised)
May 13, 2020 Audited Results & Final Dividend -
Mar 27, 2020 Others Inter alia, to consider and approve Raising of funds through issuance of Commercial Papers.
Jan 27, 2020 Quarterly Results -
Nov 01, 2019 Quarterly Results -
Jul 29, 2019 Quarterly Results -
May 17, 2019 Audited Results & Final Dividend -
Feb 01, 2019 Quarterly Results -
Oct 26, 2018 Quarterly Results -
Jul 26, 2018 Quarterly Results -
May 22, 2018 Audited Results & Dividend -
Jan 25, 2018 Quarterly Results -
Oct 31, 2017 Quarterly Results -
Jul 27, 2017 Quarterly Results -
May 12, 2017 Audited Results & Dividend -
Feb 04, 2017 Quarterly Results -
Oct 25, 2016 Quarterly Results -
Jul 26, 2016 Quarterly Results -
May 12, 2016 Audited Results & Dividend -
Feb 17, 2016 Buy Back of Shares -
Feb 09, 2016 Quarterly Results -
Oct 29, 2015 Quarterly Results -
Jul 30, 2015 Quarterly Results -
May 12, 2015 Audited Results & Final Dividend -
Jan 29, 2015 Quarterly Results -
Oct 29, 2014 Quarterly Results -
Jul 30, 2014 Quarterly Results -
May 13, 2014 Audited Results & Dividend -
Feb 11, 2014 Quarterly Results -
Oct 31, 2013 Quarterly Results -
Jul 30, 2013 Quarterly Results -
May 14, 2013 Audited Results & Dividend -
Feb 14, 2013 Quarterly Results -
Oct 30, 2012 Quarterly Results -
Jul 19, 2012 Quarterly Results -
May 11, 2012 Audited Results & Dividend -
Feb 03, 2012 Quarterly Results -
Oct 25, 2011 Quarterly Results -
Jul 20, 2011 Quarterly Results -
May 13, 2011 Audited Results & Dividend -
Jan 25, 2011 Quarterly Results -
Oct 23, 2010 Quarterly Results -
Jul 22, 2010 Quarterly Results -
May 06, 2010 Audited Results, Dividend & ESOP To grant of 16,800 stock options, exercisable at par value of Rs. 5/- to the Independent Directors of the Co. under "Dr. Reddy's ESOS, 2002" & "Dr. Reddy's Employees ADR Stock Option Scheme, 2007".
Mar 31, 2010 Issuance of Bonus Debentures For issuance of bonus debentures to Shareholders of the Co. from its General Reserves built from undistributed profits, The allotment of debentures will account for an amount not exceeding Rs. 520 Cr.
Jan 20, 2010 Quarterly Results -
Oct 23, 2009 Quarterly Results -
Jul 21, 2009 Quarterly Results -
May 18, 2009 Audited Results, Dividend & Others To grant of 9,000 stock options, exercisable at par value of Rs 5/- to the Independent Directors of the Co. under "Dr. Reddy's ESOS 2002" & "Dr. Reddy's Employees ADR Stock Option Scheme, 2007".
Jan 20, 2009 Quarterly Results -
Oct 23, 2008 Quarterly Results & Amalgamation To consider a Scheme of Amalgamation in terms of which Periecan Pharma Pvt. Ltd, a wholly owned subsidiary of the Company will be amalgamated with Dr. Reddy's Laboratories Ltd.
Jul 21, 2008 Quarterly Results -
May 20, 2008 Audited Results & Dividend -
Jan 25, 2008 Quarterly Results -
Oct 24, 2007 Quarterly Results -
Jul 23, 2007 Quarterly Results -
May 18, 2007 Audited Results & Dividend -
Jan 22, 2007 Quarterly Results -
Oct 27, 2006 Quarterly Results -
Jul 27, 2006 Quarterly Results -
May 31, 2006 Accounts & Dividend -
Jan 24, 2006 Quarterly Results -
Oct 29, 2005 Quarterly Results -
Jul 26, 2005 Quarterly Results -
May 06, 2005 Accounts & Dividend -
Jan 31, 2005 Quarterly Results -
Oct 26, 2004 Quarterly Results -
Jul 27, 2004 Quarterly Results -
Jan 30, 2004 Quarterly Results -
Oct 28, 2003 Quarterly Results -
Jul 31, 2003 Quarterly Results -
May 30, 2003 Accounts & Dividend -
Jan 28, 2003 Quarterly Results -
Oct 24, 2002 Quarterly Results -
Jul 31, 2002 Quarterly Results -
Jun 04, 2002 Accounts & Dividend -
Mar 04, 2002 Interim Dividend -
Jan 29, 2002 Quarterly Results -
Oct 31, 2001 Quarterly, H.Y. Results & I. Dividend -
Jul 31, 2001 Quarterly Results & Others Stock Split & Employees Stock Option Plan
May 30, 2001 Accounts & Dividend -
Jan 30, 2001 Quarterly Results -
Oct 30, 2000 Quarterly Results -
Jul 28, 2000 Quarterly Results -
Mar 23, 2000 Interim Dividend and Issue of ADS -
Mar 06, 2000 Merger -
Oct 20, 1999 Quarterly Results -
Jul 29, 1999 Quarterly Results -
Apr 19, 1999 Accounts & Dividend -
Jan 30, 1999 Quarterly Results -
Oct 21, 1998 Quarterly Results -
Apr 27, 1998 Accounts & Dividend -
May 17, 1997 Accounts & Dividend. -
Ex-Date Bonus Ratio Record Date
Aug 28, 2006 1:1 2006-08-29
Bigul
01 Dec 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Schedule of Analyst / Institutional Investor Meetings
Bigul
28 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Analyst/Investor Meet on 04/12/2023 - 05/12/2023
Bigul
24 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copy of newspaper publication
Bigul
23 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Bigul
21 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 Allotment of shares under ESOP/ ESPS
Bigul
20 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Analyst/Investor Meet
Bigul
17 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Analyst/Investor Meet
Bigul
17 Nov 2023

Dr Reddy's launches wearable therapy device for migraine

 Neriviocan be worn on the upper arm, each device has in-built 18 x 45-minute treatment sessions
Bigul
16 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

 Results of voting through Postal Ballot and Scrutinizer''s report
Bigul
16 Nov 2023

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press Release/Media release
See all News

FAQs

The latest market price of Dr. Reddy's Laboratories Ltd. on NSE was Rs. 5794.30 as of today.

The opening share price of Dr. Reddy's Laboratories Ltd. was Rs. 5796.00 as of today.

The 52-week high share price of Dr. Reddy's Laboratories Ltd. was Rs. 5989.70.

The 52 week low share price of Dr. Reddy's Laboratories Ltd. was Rs. 4175.10.

Dr. Reddy's Laboratories Ltd. has a market cap of Rs. 96649.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Dr. Reddy's Laboratories Ltd. is 0.30. Please refer to the Fundamentals section for further details.

The operating revenue for Dr. Reddy's Laboratories Ltd. in the last FY was Rs.  26765.50 crore. Please refer to the Financials section for further details.

The Net Profit for Dr. Reddy's Laboratories Ltd. in the last FY was Rs. 5091.20 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Dr. Reddy's Laboratories Ltd. was on 2023-07-11 for Rs. 40 per share. According to today’s share price, the dividend yield of Dr. Reddy's Laboratories Ltd. stands at 0.70. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Dr. Reddy's Laboratories Ltd. was as of 2006-08-28. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Dr. Reddy's Laboratories Ltd. was as of 2001-10-10. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Dr. Reddy's Laboratories Ltd..